Molecular cell biology of renal diseases

Journal of Nephrology

Volumn 12, Issue 3, 1999, Pages 140-149

  Menè, Paolo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Endothelial cells; Epithelial cells; Interstitial fibroblasts; Kidney glomerulus; Leukocytes; Mesangial cells; Nephritis

Indexed keywords

CYTOLOGY; ENDOTHELIUM CELL; EPITHELIUM CELL; FIBROBLAST; GENE TARGETING; GLOMERULOPATHY; GLOMERULUS; HUMAN; KIDNEY ALLOGRAFT; KIDNEY DISEASE; KIDNEY TUBULE DISORDER; LEUKOCYTE; MESANGIUM CELL; MOLECULAR BIOLOGY; NEPHRITIS; REVIEW; XENOGRAFT;

ENDOTHELIUM; EPITHELIAL CELLS; HUMANS; KIDNEY; KIDNEY DISEASES; LEUKOCYTES;

EID: 0032814436     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (95)

1. Menè P, Simonson MS, Dunn MJ. Physiology of the mesangial cell. Physiol Rev 1989; 69: 1347-424.
2. Sterzel RB, Rupprecht HD. Glomerular mesangial cells. In: Neilson EG, Couser WG, eds. Immunologic renal diseases. Philadelphia: Lippincott-Raven, 1997; pp 595-626.
3. Johnson RJ. What mediates progressive glomerulosclerosis? The glomerular endothelium comes of age. Am J Pathol 1997; 151: 1179-81.
4. Abbate M, Remuzzi G. Acceleration of recovery in acute renal failure: from cellular mechanisms of tubular repair to innovative targeted therapies. Ren Fail 1996; 18: 377-88.
5. Pabst R, Sterzel RB. Cell renewal of glomerular cell types in normal rats. An autoradiographic analysis. Kidney Int 1983; 24: 626-31.
6. Rupprecht HD, Schocklmann HO, Sterzel RB. Cell-matrix interactions in the glomerular mesangium. Kidney Int 1996; 49: 1575-82.
7. Hughes J, Johnson RJ, Mooney A, Hugo C, Gordon K, Savill J. Neutrophil fate in experimental glomerular capillary injury in the rat. Emigration exceeds in situ clearance by apoptosis. Am J Pathol 1997; 150: 223-34.
8. Savill J. Apoptosis and the kidney. J Am Soc Nephrol 1994; 5: 12-21.
9. Johnson RJ, Raines EW, Floege J, Yoshimura A, Pritzl P, Alpers CE, Ross R. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 1992; 175: 1413-6.
10. Isaka Y, Brees DK, Ikegaya K, Kaneda Y, Imai E, Noble NA, Border WA. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nature Med 1996; 2: 418-23.
11. Zarnegar R, Michalopoulos GK. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 1995; 129: 1177-80.
12. Floege J, Burg M, Hugo C, Gordon KL, Van Goor H, Reidy M, Couser WG, Koch KM, Johnson RJ. Endogenous fibroblast growth factor-2 mediates cytotoxicity in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol 1998; 9: 792-801.
13. Simon M, Grone H-J, Jōhren O, Kullmer J, Plate KH, Risau W, Fuchs E. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 1995; 268: F240-F50.
14. Baylis C, Bloch J. Nitric oxide (NO) in renal physiology and pathophysiology. Nephrol Dial Transplant 1996; 11: 1955-7.
15. Kone BC. Nitric oxide in renal health and disease. Am J Kidney Dis 1997; 30: 311-33.
16. Beck KF, Sterzel RB. Cloning and sequencing of the proximal promoter of the rat iNOS gene: activation of NFkappaB is not sufficient for transcription of the iNOS gene in rat mesangial cells. FEBS Lett 1996; 394: 263-7.
17. Elger M, Kaissling B, Le Hir M, Kriz W. Microanatomy of the kidney: vessels, interstitium, and glomerulus. In: Neilson EG, Couser WG, eds. Immunologic renal diseases. Philadelphia: Lippincott-Raven, 1997; 15.
18. Ophascharoensuk V, Pippin JW, Gordon KL, Shankland SJ, Couser WG, Johnson RJ. Role of intrinsic renal cells versus infiltrating cells in glomerular crescent formation. Kidney Int 1998; 54:416-25.
19. Menè P, Amore A. Apoptosis: potential role in renal diseases. Nephrol Dial Transplant 1998; 13: 1936-43.
20. Hale AJ, Smith CA, Sutherland LC, Stoneman VE, Longthorne VL, Culhane AC, Williams GT. Apoptosis: molecular regulation of cell death. EurJ Biochem 1996; 236: 1-26.
21. Takemura T, Murakami K, Miyazato H, Yagi K, Yoshioka K. Expression of Fas antigen and Bcl-2 in human glomerulonephritis. Kidney Int 1995; 48: 1886-92.
22. Ortiz-Arduan A, Danoff TM, Kalluri R, Gonzalez-Cuadrado S, Karp SL, Elkon K, Egido J, Neilson EG. Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia. Am J Physiol 1996; 271: F1193-F201.
23. Nakopoulou L, Stefanaki K, Papadakis J, Boletis J, Zeis PM, Kostakis A, Vosnides G. Expression of Bcl-2 oncoprotein in various types of glomerulonephritis and renal allografts. Nephrol Dial Transplant 1996; 11: 997-1002.
24. Meehan SM, McCluskey RT, Pascual M, Preffer FI, Anderson P, Schlossman SF, Colvin RB. Cytotoxicity and apoptosis in human renal allografts: identification, distribution, and quantitation of cells with a cytotoxic granule protein GMP-17 (TIA-1) and cells with fragmented nuclear DNA. Lab Invest 1997; 76: 639-149
25. Thomas GL, Yang B, Wagner BE, Savill J, El Nahas AM. Cellular apoptosis and proliferation in experimental renal fibrosis. Nephrol Dial Transplant 1998; 13: 2216-26.
26. Grantham JJ. Polycystic kidney disease: there goes the neighborhood. N Engl J Med 1995; 333: 18-25.
27. Woo D. Apoptosis and loss of renal tissue in polycystic kidney disease. N Engl J Med 1995; 333: 56-7.
28. Soto H, Mosquera J, Rodriguez-Iturbe B, Henriquez La Roche C, Pinto A. Apoptosis in proliferative glomerulonephritis: decreased apoptosis expression in lupus nephritis. Nephrol Dial Transplant 1997; 12: 273-80.
29. Tax WJM, Kramers C, van Bruggen MCJ, Berden JHM. Apoptosis, nucleosomes, and SLE nephritis. Kidney Int 1995; 48: 666-73.
30. Kashgarian M. Lupus nephritis: lessons from the path lab. Kidney Int 1994; 45: 928-38.
31. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z. Apoptosis in glomerular sclerosis. Kidney Int 1996; 49: 103-11.
32. Eddy AA, Giachelli CM. Renal expression of genes that promote interstitial inflammation and fibrosis with protein-overload proteinuria. Kidney Int 1995; 47: 1546-57.
33. Ortiz A, Ziyadeh FN, Neilson EG. Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys. J Invest Med 1997; 45: 50-6.
34. Ballermann BJ. Regulation of bovine glomerular endothelial cell growth in vitro. Am J Physiol 1989; 256 (Cell Physiol 25): C182-9.
35. van Setten PA, van Hinsbergh VW, van der Velden TJ, van de Kar NC, Vermeer M, Mahan JD, Assmann KJ, van den Heuvel LP, Monnens LA. Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Int 1997; 51: 1245-56.
36. Morigi M, Zoja C, Figliuzzi M, Foppolo M, Micheletti G, Bontempelli M, Saronni M, Remuzzi G, Remuzzi A. Fluid shear stress modulates surface expression of adhesion molecules by endothelial cells. Blood 1997; 85: 1696-703.
37. Remuzzi G, Ruggenenti P. The hemolytic uremic syndrome. Kidney Int 1995; 47: 2-19.
38. Thiemermann C. Nitric oxide and septic shock. Gen Pharmacol 1997; 29: 159-66.
39. Tedder TF, Steeber DA, Chen A, Engel P. The selectins: vascular adhesion molecules. FASEB J 1995; 9: 866-73.
40. Colvin RB. The renal allograft biopsy. Kidney Int 1996; 50: 1069-82.
41. Nørgaard JOR. Rat glomerular epithelial cells in culture: parietal or visceral epithelial origin? Lab Invest 1987; 57: 277-90.
42. Coers W, Reivinen J, Miettinen A, Huitema S, Vos JTMW, Salant DJ, Weening JJ. Characterization of a rat glomerular visceral epithelial cell line. Exp Nephrol 1996; 4: 184-92.
43. Mundel P, ReiserJ, Kriz W. Induction of differentiation in cultured rat and human podocytes. J Am Soc Nephrol 1997; 8: 697-705.
44. Artero ML, Sharma R, Savin VJ, Vincenti F. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 1994; 23: 574-81.
45. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996; 334: 878-83.
46. Kriz W. Progressive renal failure - inability of podocytes to replicate and the consequences for development of glomerulosclerosis. Nephrol Dial Transplant 1996; 11: 1738-42.
47. Kriz W, Gretz N, Lemley KV. Progression of glomerular diseases: is the podocyte the culprit? Kidney Int 1998; 54: 687-97.
48. D'Agati V. The many masks of focal segmental glomerulosclerosis. Kidney Int 1994; 46: 1223-41.
49. Atkins RC, Nikolic-Paterson DJ, Song Q, Lan HY. Modulators of crescentic glomerulonephritis. J Am Soc Nephrol 1996; 7: 2271-8.
50. Howie AJ, Brewer DB. The glomerular tip lesion: a previously undescribed type of segmental glomerular abnormality. J Pathol 1984; 142: 205-20.
51. Yaqoob M, Edelstein CL, Schrier RW. Role of nitric oxide and superoxide balance in hypoxia reoxygenation proximal tubular injury. Nephrol Dial Transplant 1996; 11: 1743-6.
52. Zager RA. Pathogenetic mechanisms in nephrotoxic acute renal failure. Semin Nephrol 1997; 17: 3-14.
53. Abbate M, Zoja C, Corna D, Capitanio M, Bertani T, Remuzzi G. In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. J Am Soc Nephrol 1998; 9:1213-24.
54. Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, Morigi M, Remuzzi G. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int 1998; 53: 1608-15.
55. Amore A, Cirina P, Iavarone A, Fiorucci GC, Coppo R. Proteinuria induces apoptosis in cultured tubular cells. J Am Soc Nephrol 1996; 7: 1691 (abstract).
56. Ronco PM, Mougenot B, Touchard G, Preud'homme JL, Aucouturier P. Renal involvement in hematological disorders: monoclonal immunoglobulins and nephropathy. Curr Opin Nephrol Hypertens 1995; 4: 130-8.
57. D'Amico G, Ferrario F, Rastaldi MP. Tubulointerstitial damage in glomerular diseases: its role in the progression of renal damage. Am J Kidney Dis 1995; 26: 124-32.
58. Ruggenenti P, Perna A, Gherardi G, Gaspari F, Benini R, Remuzzi G. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. GISEN - Ramipril efficacy in nephropathy. Lancet 1998; 352: 1252-6.
59. Visweswaran P, Massin EK, Dubose TD Jr. Mannitol-indticed acute renal failure. J Am Soc Nephrol 1997; 8: 1028-33.
60. Solomon R, Werner C, Mann D, D'Ellia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1995; 331: 1416-20.
61. Zager RA. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 1996; 49: 314-26.
62. Fogazzi GB, Imbasciati E, Moroni G, Scalia A, Mihatsch MJ, Ponticelli C. Reversible acute renal failure from gross hematuria due to glomerulonephritis: not only in IgA nephropathy and not associated with intratubular obstruction. Nephrol Dial Transplant 1995; 10: 624-9.
63. Grantham JJ. The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: recent advances. Am J Kidney Dis 1996; 28: 788-803.
64. Lanoix J, D'Agati V, Szabolcs M, Trudel M. Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD). Oncogene 1996; 13: 1153-60.
65. Winyard PJD, Nauta J, Lirenman DS, Hardman P, Sams VR, Risdon RA, Woolf AS. Deregulation of cell survival in cystic and dysplastic renal development. Kidney Int 1996; 49: 135-46.
66. Sorenson CM, Padanilam BJ, Hammerman MR. Abnormal postpartum renal development and cystogenesis in the Bcl-2 (-/-) mouse. Am J Physiol 1996; 271: F184-93.
67. Muller GA, Frank J, Rodemann HP, Engler-Blumm G. Human renal fibroblast cell lines (tFKIF and tNKF) are new tools to investigate pathophysiologic mechanisms of renal interstitial fibrosis. Exp Nephrol 1995; 3: 127-33.
68. Johnson RJ, Schreiner GF. Hypothesis: the role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension. Kidney Int 1997; 52: 1169-79.
69. Alpers CE, Hudkins KL, Gown AM, Johnson RJ. Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int 1992; 41: 1134-42.
70. Johnson RJ, Floege J, Yoshimura A, Lida H, Couser WG, Alpers CE. The activated mesangial cell: a glomerular "myofibroblast"? J Am Soc Nephrol 1992; 2: S190-7.
71. Latta H. An approach to the structure and function of the glomerular mesangium. J Am Soc Nephrol 1992; 2: S65-73.
72. Zhang G, Moorhead P, El Nahas A. Myofibroblasts and the progression of experimental glomerulonephritis. Exp Nephrol 1995; 3: 308-18.
73. Kriz W, Elger M, Lemley K, Sakai T. Structure of the glomerular mesangium: a biomechanical interpretation. Kidney Int 1990; 38 (suppl.30): S2-9.
74. Fioretto P, Steffes MW, Sutherland DER, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Eng J Med 1998; 339: 69-75.
75. Menè P, Pugliese G, Pricci F, Di Mario U, Cinotti GA, Pugliese F. High glucose level inhibits capacitative Ca2+ influx in cultured rat mesangial cells by a protein kinase C-dependent mechanism. Diabetologia 1997; 40: 521-7.
76. Di Paolo S, Gesualdo L, Ranieri E, Grandaliano G, Schena FP. High glucose concentration induces the overexpression of transforming growth factor-β through the activation of a platelet-derived growth factor loop in human mesangial cells. Am J Pathol 1996; 149: 2095-106.
77. Sterzel RB, Lovett DH, Foellmer HG, Perfetto M, Biemesderfer D, Kashgarian M. Mesangial cell hillocks. Nodular foci of exaggerated growth of cells and matrix in prolonged culture. Am J Pathol 1986; 125: 130-40.
78. Glass WF, Teng PR, Haney LB. Extracellular matrix distribution and hillock formation in human mesangial cells in culture without serum. J Am Soc Nephrol 1996; 7: 2230-43.
79. Marx M, Daniel TO, Kashgarian M, Madri JA. Spatial organization of the extracellular matrix modulates the expression of PDGF-receptor subunits in mesangial cells. Kidney Int 1993; 43: 1027-41.
80. Yaoita E. Behavior of rat mesangial cells cultured within extracellular matrix. Lab Invest 1989; 61: 410-18.
81. Cattell V. Macrophages in acute glomerular inflammation. Kidney Int 1994; 45: 945-52.
82. Nikolic-Paterson DL, Lan HY, Hill PA, Atkins RC. Macrophages in renal injury. Kidney Int 1994; 45 (suppl. 45): S79-82.
83. Floege J, Ostendorf T, Janssen U, Burg M, Radeke HH, Vargeese C, Gill SC, Green LS, Janjic N. Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. Am J Pathol 1999; 154: 169-79.
84. Menè P, Fais S, Cinotti GA, Pugliese F, Luttmann W, Thierauch K-H. Regulation of U-937 monocyte adhesion to cultured human mesangial cells by cytokines and vasoactive agents. Nephrol Dial Transplant 1995; 10: 481-9.
85. Menè P, Pugliese F, Cinotti GA. Adhesion of U-937 monocytes induces cytotoxic damage and subsequent proliferation of cultured human mesangial cells. Kidney Int 1996; 50: 4171-23.
86. Wheeler DC, Chana RS. Mechanisms of monocyte adhesion to lipoprotein-and cytokine-stimulated mesangial cells. Exp Nephrol 1998; 6: 157 (abstract).
87. Heidenreich S, Sato T, Schmidt M, August C, Timmerman JJ, van Es LA, Daha MR. Induction of mesangial interleukin-6 synthesis by apoptotic U-937 cells and monocytes. Kidney Int 1997; 52: 128-318.
88. Brady HR, Denton MD, Jimenez W, Takata S, Palliser D, Brenner BM. Chemoattractants provoke monocyte adhesion to human mesangial cells and mesangial cell injury. Kidney Int 1992; 42: 480-7.
89. Mattana J, Singhal PC. Macrophage supernatants have both stimulatory and suppressive effects on mesangial cell proliferation. J Cell Physiol 1993; 154: 289-93.
90. Mattana J, Jaffer S, Singhal PC. Effects of macrophage supernatants on mesangial cell migration and hillock formation. Proc Soc Exp Biol Med 1995; 208: 271-6.
91. Kasai S, Mori T, Komiyama A, Ito N, Shigematsu H. The importance of cellular adhesion for mesangial cell proliferation in serum sickness nephritis of the rat: a co-culture study of glomerular macrophages and mesangial cells. Path Int 1994; 44: 413-9.
92. Menè P, Pecci G, Cinotti GA, Pugliese G, Pricci F, Pugliese F. Eicosanoid synthesis in peripheral blood monocytes: a marker of disease activity in lupus nephritis. Am J Kidney Dis 1998; 32: 778-84.
93. Tomasoni S, Noris M, Zappella S, Gotti E, Casiraghi F, Bonazzola S, Benigni A, Remuzzi G. Upregulation of renal and systemic cyclooxygenase-2 in patients with active lupus nephritis. J Am Soc Nephrol 1998; 9: 1202-12.
94. Strehlau J, Pavlakis M, Lipman M, Shapiro M, Vasconcellos L, Harmon W, Strom TB. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA 1997; 94: 695-700.
95. Kitamura M. Genetic manipulation of the kidney: round one. Exp Nephrol 1997; 5: 109-11.